PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery

PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery

Despite major advances in the understanding of the pathogenesis of idiopathic pulmonary fibrosis (IPF), diagnosis and management of the condition continue to pose significant challenges. Clinical management of IPF remains unsatisfactory due to limited availability of effective drug therapies, a lack...

Full description

Bibliographic Details
Main Author: Toby M. Maher
Format: Article
Language:English
Published: European Respiratory Society 2013-06-01
Series:European Respiratory Review
Subjects:
Biomarkers
clinical management
idiopathic pulmonary fibrosis
pharmacological treatment
PROFILE study
prognosis
Online Access:http://err.ersjournals.com/content/22/128/148.full.pdf+html

Internet

http://err.ersjournals.com/content/22/128/148.full.pdf+html

Similar Items